You are here

Sinovac's vaccine trial data suggest potential in virus defence

ym-sinovac-140620.jpg
Sinovac Biotech said its coronavirus shot is safe and capable of eliciting an immune response from human trials, suggesting the shot's potential in defending against infection of the novel coronavirus.

[BEIJING] Sinovac Biotech said its coronavirus shot is safe and capable of eliciting an immune response from human trials, suggesting the shot's potential in defending against infection of the novel coronavirus.

The Beijing-based company's vaccine, called CoronaVac, hasn't caused severe...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes